Table 3.
Biochemical parameters of hepatitis B virus-induced fibrosis and hepatitis C patients after treatment
Conventional group |
AHM group |
|||
Parameter | HBV (n = 12 ) | HCV (n = 8 ) | HBV (n = 12 ) | HCV (n = 7 ) |
ALT (IU/L) | 50.1 | 47.2 | 50.1 | 37.3 |
AST (IU/L) | 40.4 | 38.3 | 30.3 | 28.1 |
ALP (IU/L) | 173.3 | 177.8 | 156.3 | 160.4 |
MDA (μmol/g) | 596.1 | 607.4 | 571.0 | 565.0 |
GSH (μg/g) | 22.9 | 20.4 | 23.7 | 27.6 |
TGF-β (pg/mL) | 38.2 | 41.1 | 34.6 | 38.4 |
HA (ng/mL) | 63.3 | 59.7 | 58.1 | 52.1 |
MMP-2 (ng/mL) | 259.1 | 277.8 | 238.8 | 256.7 |
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; MDA: Malondialdhyde; GSH: Reduced glutathione; TGF-β: Transforming growth factor-β; HA: Hyaluronic acid; MMP-2: Matrix metalloproteinase-2; HBV: Hepatitis B virus; HCV: Hepatitis C virus.